Announcements Trials
Browse Landscape

Phase

Phase 1/2 19Phase NA 15Phase 2 9Phase 2/3 5Phase 1 4Phase 4 3Phase 3 2Phase EARLY_PHASE1 1

Status

Completed 5Withdrawn 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Breast 1

Conditions

Unresectable Pancreatic Cancer 1Small Cell Lung Carcinoma 1Liver, Cancer of, Non-Resectable 1Advanced Intestinal Cancer 1Advanced Breast Cancer 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Cryosurgery × Clear all
NCT03239158 2019-01-25

Bioinformation Therapy for Liver Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled

Liver, Cancer of, Non-Resectable

NCT03239171 2019-01-25

Bioinformation Therapy for Lung Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03239184 2019-01-25

Bioinformation Therapy for Pancreatic Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Gastrointestinal

Unresectable Pancreatic Cancer

NCT03240224 2019-01-25

Bioinformation Therapy for Breast Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Breast

Advanced Breast Cancer

NCT03350490 2019-01-25

Bioinformation Therapy for Intestinal Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled

Advanced Intestinal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡